CES 2022: Abbott CEO Robert Ford Announces New Biowearables Line For Consumers, Paving The Way From Measuring Glucose To Ketone, Lactate, Alcohol

Abbott announced today at CES 2022 it is developing a new line of consumer wearables, starting with a device to track ketones continuously, which is expected to launch in Europe this year. 

Lingo
• Source: Abbott

Abbott’s CEO Robert Ford today seized the occasion of his keynote at the 2022 Consumer Electronics Show to unveil the company’s plans for a new line of consumer biowearables called Lingo. 

More from Digital Technologies

More from Medtech Insight